These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8578441)

  • 21. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombolysis in cardiopulmonary resuscitation].
    Spöhr F; Böttiger BW
    Hamostaseologie; 2007 Dec; 27(5):356-9. PubMed ID: 18060246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombolytic agents in myocardial infarction: results of large mortality studies].
    Slama MS; Motté G
    Rev Prat; 1992 Nov; 42(17):2143-9. PubMed ID: 1290036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary embolism.
    Olin JW
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S68-75. PubMed ID: 12556745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal epidural hematoma after intravenous thrombolysis for acute ischemic stroke.
    Yeo LL; Lim JS; Sharma VK
    J Neurol Sci; 2009 Sep; 284(1-2):190-1. PubMed ID: 19411083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolytic therapy during or after cardiopulmonary resuscitation. Efficacy and safety of a new therapeutic approach.
    Spöhr F; Böttiger BW
    Minerva Anestesiol; 2003 May; 69(5):357-64. PubMed ID: 12768167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor.
    Han S; Chaya C; Hoo GW
    J Intensive Care Med; 2006; 21(4):240-5. PubMed ID: 16855059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What have we learned from large trials?].
    Lai C; Cherchi A
    Cardiologia; 1991 Dec; 36(12 Suppl 1):403-12. PubMed ID: 1841797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary thrombolysis: mortality trials.
    Cairns JA
    Can J Cardiol; 1993; 9(6):490-7. PubMed ID: 8221341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracranial hemorrhage after thrombolytic therapy. A perspective.
    Simoons ML; de Jaegere P; van Domburg R; Boersma E
    Z Kardiol; 1993; 82 Suppl 2():153-6. PubMed ID: 8328195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolysis for pulmonary embolism: Past, present and future.
    Lankeit M; Konstantinides S
    Thromb Haemost; 2010 May; 103(5):877-83. PubMed ID: 20216979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombolytic therapy of acute myocardial infarct: which drugs? Which patients?].
    Pachinger O; Punzengruber C
    Wien Med Wochenschr; 1988 Aug; 138(15-16):373-9. PubMed ID: 3051693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methods for evaluating thrombolytic drugs].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():9-14. PubMed ID: 2108647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current status of thrombolysis. The need for coadjuvant antithrombotic therapy].
    García Frade LJ; García Avello A
    Rev Clin Esp; 1993 Jun; 193(2):88-92. PubMed ID: 8341821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Findings on the efficacy and safety of thrombolytic therapy. An analysis of key clinical trials.
    Ventura B
    Crit Care Nurs Clin North Am; 1990 Dec; 2(4):663-71. PubMed ID: 2096871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic agents: balancing cost, efficacy, and side effects.
    Marder VJ
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI37-41. PubMed ID: 2112990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombolysis during cardio-pulmonary resuscitation].
    Wetsch WA; Spöhr F; Teschendorf P; Böttiger BW; Padosch SA
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1983-8. PubMed ID: 20922642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clarifying the conundrum of conjunctive anticoagulation and coronary thrombolysis.
    Sobel BE
    Coron Artery Dis; 1995 Jan; 6(1):83-6. PubMed ID: 7767507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.